4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-022219
Options or other derivatives
- Chief Clin. Ops. Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MAIDA ANTHONY E III · Chief Clin. Ops. Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-03 | Grant or award : show line 1 in the form Stock Options | +600,000 | 600,000 | D |
Loading xslF345X03/ownership.xml…